MedTrace Logo

Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura

NCT00467571 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2013-05-03

No results posted yet for this study

Summary

Previous studies suggest that chronic idiopathic thrombocytopenic purpura is associated with Helicobacter pylori infection. The objective is to study the effect of Helicobacter pylori eradication on platelet count.

Conditions

  • Chronic Idiopathic Thrombocytopenic Purpura
  • Helicobacter Pylori Infection

Interventions

DRUG

lansoprazole, clarithromycin, amoxycillin

lansoprazole (15, 30 mg) 1 tab twice daily, clarithromycin 7.5 mg/kg twice daily, amoxycillin 25 mg/kg twice daily; rout: orally; duration 14 days

Sponsors & Collaborators

  • Ramathibodi Hospital

    collaborator OTHER

  • Mahidol University

    lead OTHER

Principal Investigators

  • Suporn Treepongkaruna, M.D. · Ramathibodi Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2008-09-30
Completion
2008-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00467571 on ClinicalTrials.gov